KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 117 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $217,000 | +17.3% | 30,000 | 0.0% | 0.03% | -5.6% |
| Q1 2017 | $185,000 | +5.1% | 30,000 | 0.0% | 0.04% | +125.0% |
| Q4 2016 | $176,000 | +10.7% | 30,000 | 0.0% | 0.02% | -40.7% |
| Q3 2016 | $159,000 | -20.1% | 30,000 | 0.0% | 0.03% | -38.6% |
| Q2 2016 | $199,000 | +42.1% | 30,000 | 0.0% | 0.04% | +33.3% |
| Q1 2016 | $140,000 | +68.7% | 30,000 | +81.8% | 0.03% | +73.7% |
| Q4 2015 | $83,000 | – | 16,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |